Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Higuchi

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Pediatric Blood & Cancer|February 21, 2022
An efficient diagnosis: A patient with X-linked inhibitor of apoptosis protein (XIAP) deficiency in the setting of infantile hemophagocytic lymphohistiocytosis was diagnosed using high serum interleukin-18 combined with common laboratory parametersToru Higuchi, Kazushi Izawa, Takayuki Miyamoto, et al.
Plos One|May 27, 2016
Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast CancerToru Higuchi, Megumi Endo, Toru Hanamura, et al.
Journal of Equine Science|January 26, 2023
Prevalence of equine proliferative enteropathy in Hidaka district, Hokkaido, over five seasonsHidekazu Niwa, Toru Higuchi, Seiichi Fujii, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2011
[Efficacy of oxycodone against anti-cancer agent-induced pain in breast cancer patients during adjuvant treatment before and after surgery]Kenichi Inoue, Shigenari Nagai, Shihori Kaneko, et al.
Surgical Case Reports|February 28, 2023
A long-term survival case of histiocytic sarcoma by surgery alone in a Japanese elderly breast tumor patientToru Higuchi, Chih-Ping Li, Yuko Hirota, et al.
Clinical Breast Cancer|December 17, 2013
Variation in use of estrogen receptor-α gene promoters in breast cancer compared by quantification of promoter-specific messenger RNAToru Higuchi, Tatsuyuki Gohno, Takamasa Nagatomo, et al.
Cancer Diagnosis & Prognosis|November 6, 2023
The Impact of Being Underweight on the Prognosis of Older Patients With Early Breast CancerYumiko Ishizuka, Yoshiya Horimoto, Midori Morita, et al.
Anticancer Research|June 9, 2016
Clinicopathological Features of Cases with Primary Breast Cancer not Identified by 18F-FDG-PETTakaaki Fujii, Reina Yajima, Miki Tsuboi, et al.
Anticancer Research|November 1, 2016
Clinical Significance of 18F-FDG-PET in Invasive Lobular CarcinomaTakaaki Fujii, Reina Yajima, Sasagu Kurozumi, et al.
Breast Cancer (Tokyo, Japan)|January 15, 2022
Is adjuvant chemotherapy necessary in older patients with breast cancer?Midori Morita, Akihiko Shimomura, Emi Tokuda, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|February 21, 2022
An efficient diagnosis: A patient with X-linked inhibitor of apoptosis protein (XIAP) deficiency in the setting of infantile hemophagocytic lymphohistiocytosis was diagnosed using high serum interleukin-18 combined with common laboratory parametersToru Higuchi, Kazushi Izawa, Takayuki Miyamoto, et al.
Plos One|May 27, 2016
Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast CancerToru Higuchi, Megumi Endo, Toru Hanamura, et al.
Journal of Equine Science|January 26, 2023
Prevalence of equine proliferative enteropathy in Hidaka district, Hokkaido, over five seasonsHidekazu Niwa, Toru Higuchi, Seiichi Fujii, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2011
[Efficacy of oxycodone against anti-cancer agent-induced pain in breast cancer patients during adjuvant treatment before and after surgery]Kenichi Inoue, Shigenari Nagai, Shihori Kaneko, et al.
Surgical Case Reports|February 28, 2023
A long-term survival case of histiocytic sarcoma by surgery alone in a Japanese elderly breast tumor patientToru Higuchi, Chih-Ping Li, Yuko Hirota, et al.
Clinical Breast Cancer|December 17, 2013
Variation in use of estrogen receptor-α gene promoters in breast cancer compared by quantification of promoter-specific messenger RNAToru Higuchi, Tatsuyuki Gohno, Takamasa Nagatomo, et al.
Cancer Diagnosis & Prognosis|November 6, 2023
The Impact of Being Underweight on the Prognosis of Older Patients With Early Breast CancerYumiko Ishizuka, Yoshiya Horimoto, Midori Morita, et al.
Anticancer Research|June 9, 2016
Clinicopathological Features of Cases with Primary Breast Cancer not Identified by 18F-FDG-PETTakaaki Fujii, Reina Yajima, Miki Tsuboi, et al.
Anticancer Research|November 1, 2016
Clinical Significance of 18F-FDG-PET in Invasive Lobular CarcinomaTakaaki Fujii, Reina Yajima, Sasagu Kurozumi, et al.
Breast Cancer (Tokyo, Japan)|January 15, 2022
Is adjuvant chemotherapy necessary in older patients with breast cancer?Midori Morita, Akihiko Shimomura, Emi Tokuda, et al.
Pageof 5